Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Avacta Group plc, is pleased to announce an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co.Ltd and AffyXell Therapeutics.

29 Jul 2020

Telemedicine services can help expand patients' access to specialized medical care

Safety new medical providers can substantially increase their telemedicine services with modest investments in new staff and technology, a move that can help them expand patients' access to specialized medical care, according to a new RAND Corporation study.

29 Jul 2020

Inconsistent SARS-CoV-2 antibody results in nephrology workers

Using a broad spectrum of antibody tests the present study revealed inconsistent results for SARS-CoV-2 seroprevalence among asymptomatic individuals, while this was not the case among Covid-19 patients.

29 Jul 2020

Platelet hyperreactivity, a unique feature of COVID-19

A new study by Irish researchers and published in the preprint server medRxiv in July 2020 reports a bidirectional relationship between COVID-19 and coagulation abnormalities.

29 Jul 2020

Computed tomography can serve as effective tool for diagnosing COVID-19

The use of computed tomography in outpatient computed tomography centers (OCTC) is entirely consistent with the clinical data and global best practices. This is also an effective tool for diagnosing the coronavirus infection COVID-19

29 Jul 2020

Recurrent SARS-CoV-2 positives not infectious in discharged COVID-19 patients, says Chinese study

A new research paper from China published on the preprint server medRxiv* claims that recurrent positive results for SARS-CoV-2 are due to the presence of low levels of viral RNA fragments and not the shedding of infectious virus particles.

29 Jul 2020

Exciting cost-effective SARS-CoV-2 vaccine candidate using Newcastle disease

Experts warn that the world may see repeated waves of the COVID-19 pandemic. However, scientists around the world are working hard to create a protective vaccine or antiviral, which could help to reduce the number of deaths and cases the next time around.

29 Jul 2020

Case Fatality Rate alone may be a misleading measure of overall COVID-19 mortality

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 16.67 million individuals and caused over 659,000 deaths around the world. Commonly the deadly virus and its impact are measured by the case fatality ratio (CFR).

29 Jul 2020

Mental health problems peak alongside COVID-19 in Australia

A new study has found that during the peak of the outbreak in Australia, the rates of psychological distress, anxiety, and depression symptoms rose among adults. The study is published in the latest issue of the journal PLOS ONE.

29 Jul 2020

Sniffer dogs detect COVID-19 infections with 94 percent accuracy

Dogs have an acute sense of smell. They have up to 300 million olfactory receptors in their noses, compared to six million in humans, making their smell receptors up 10,000 to 100,000 more powerful than humans.

28 Jul 2020

Which face masks works best against COVID-19?

Wearing face masks is widely recommended as the coronavirus disease (COVID-19) continues to ravage across the globe. The pandemic has now topped more than 16.66 million cases, with a staggering death toll of at least 659,000.

28 Jul 2020

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

By using specialized assays customized to detect specific receptor interactions, researchers from the Wellcome Sanger Institute in Cambridge UK find no evidence for direct binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein to a transmembrane glycoprotein known as basigin.

28 Jul 2020

Emergent SARS-CoV-2 D614G spike mutation more infective due to "open" morphology

Researchers from the Los Alamos National Laboratory and Duke Human Vaccine Institute & Department of Surgery demonstrated that globally prevalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the amino acid substitution D614G in the spike protein is much more infective due to profitable binding encounters with the host receptors.

28 Jul 2020

Researchers examine specifications for mass acceptance of contact-tracing apps

Coronavirus tracing applications for the detection of infection chains are currently being developed and made available across the world.

28 Jul 2020

Experimental vaccine rapidly controls coronavirus in the upper and lower airways of nonhuman primates

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, report scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. SARS-CoV-2 is the virus that causes COVID-19.

28 Jul 2020

Computational analyses suggest new pathway for inflammatory response to SARS-CoV-2

Analyses of lung fluid cells from COVID-19 patients conducted on the nation's fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body's response to SARS-CoV-2.

28 Jul 2020

Study analyzes how the coronavirus spreads indoors

A new study from the University of Minnesota College of Science and Engineering analyzes how the coronavirus spreads indoors-;information that could help businesses and schools take precautions to reduce the chance of COVID-19 transmission as they reopen.

28 Jul 2020

Ergonomic lessons from the 'new normal' of working from home

Taking a few minutes to get that periodic cup of joe might not be such a bad idea.

28 Jul 2020

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

According to new research, the failure to protect tropical rain forests has cost trillions of dollars stemming from the coronavirus pandemic, which has wreaked economic havoc and caused historic levels of unemployment in the United States and around the world.

28 Jul 2020

Evolutionary origins of SARS-CoV-2 identified

By reconstructing the evolutionary history of SARS-CoV-2, the virus that is responsible for the COVID-19 pandemic, an international research team of Chinese, European and U.S. scientists has discovered that the lineage that gave rise to the virus has been circulating in bats for decades and likely includes other viruses with the ability to infect humans.

28 Jul 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy

Telemedicine services can help expand patients' access to specialized medical care

Inconsistent SARS-CoV-2 antibody results in nephrology workers

Platelet hyperreactivity, a unique feature of COVID-19

Computed tomography can serve as effective tool for diagnosing COVID-19

Recurrent SARS-CoV-2 positives not infectious in discharged COVID-19 patients, says Chinese study

Exciting cost-effective SARS-CoV-2 vaccine candidate using Newcastle disease

Case Fatality Rate alone may be a misleading measure of overall COVID-19 mortality

Mental health problems peak alongside COVID-19 in Australia

Sniffer dogs detect COVID-19 infections with 94 percent accuracy

Which face masks works best against COVID-19?

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Emergent SARS-CoV-2 D614G spike mutation more infective due to "open" morphology

Researchers examine specifications for mass acceptance of contact-tracing apps

Experimental vaccine rapidly controls coronavirus in the upper and lower airways of nonhuman primates

Computational analyses suggest new pathway for inflammatory response to SARS-CoV-2

Study analyzes how the coronavirus spreads indoors

Ergonomic lessons from the 'new normal' of working from home

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

Evolutionary origins of SARS-CoV-2 identified

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in